nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC15A1—Lisinopril—systemic scleroderma	0.417	0.572	CbGbCtD
Cefepime—SLC15A1—Captopril—systemic scleroderma	0.312	0.428	CbGbCtD
Cefepime—Dyspnoea—Mometasone—systemic scleroderma	0.00057	0.00211	CcSEcCtD
Cefepime—Confusional state—Captopril—systemic scleroderma	0.000567	0.00209	CcSEcCtD
Cefepime—Anaphylactic shock—Captopril—systemic scleroderma	0.000562	0.00208	CcSEcCtD
Cefepime—Chills—Mycophenolic acid—systemic scleroderma	0.000558	0.00206	CcSEcCtD
Cefepime—Hallucination—Lisinopril—systemic scleroderma	0.000557	0.00206	CcSEcCtD
Cefepime—Dysgeusia—Leflunomide—systemic scleroderma	0.000556	0.00205	CcSEcCtD
Cefepime—Anaemia—Azathioprine—systemic scleroderma	0.000555	0.00205	CcSEcCtD
Cefepime—Vaginal inflammation—Methotrexate—systemic scleroderma	0.000554	0.00205	CcSEcCtD
Cefepime—Shock—Captopril—systemic scleroderma	0.000553	0.00204	CcSEcCtD
Cefepime—Thrombocytopenia—Captopril—systemic scleroderma	0.00055	0.00203	CcSEcCtD
Cefepime—Pneumonia—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00203	CcSEcCtD
Cefepime—Pain—Mometasone—systemic scleroderma	0.000547	0.00202	CcSEcCtD
Cefepime—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000546	0.00202	CcSEcCtD
Cefepime—Leukopenia—Azathioprine—systemic scleroderma	0.000538	0.00199	CcSEcCtD
Cefepime—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000537	0.00199	CcSEcCtD
Cefepime—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.000535	0.00198	CcSEcCtD
Cefepime—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.000531	0.00196	CcSEcCtD
Cefepime—Erythema multiforme—Lisinopril—systemic scleroderma	0.00053	0.00196	CcSEcCtD
Cefepime—Pruritus—Pentoxifylline—systemic scleroderma	0.000525	0.00194	CcSEcCtD
Cefepime—Anaemia—Leflunomide—systemic scleroderma	0.000524	0.00194	CcSEcCtD
Cefepime—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000523	0.00193	CcSEcCtD
Cefepime—Vaginal infection—Methotrexate—systemic scleroderma	0.000523	0.00193	CcSEcCtD
Cefepime—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00052	0.00192	CcSEcCtD
Cefepime—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00188	CcSEcCtD
Cefepime—Leukopenia—Leflunomide—systemic scleroderma	0.000508	0.00188	CcSEcCtD
Cefepime—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000507	0.00187	CcSEcCtD
Cefepime—Coma—Methotrexate—systemic scleroderma	0.000506	0.00187	CcSEcCtD
Cefepime—Abdominal pain—Mometasone—systemic scleroderma	0.000506	0.00187	CcSEcCtD
Cefepime—Body temperature increased—Mometasone—systemic scleroderma	0.000506	0.00187	CcSEcCtD
Cefepime—Paraesthesia—Captopril—systemic scleroderma	0.000505	0.00186	CcSEcCtD
Cefepime—Chills—Lisinopril—systemic scleroderma	0.000503	0.00186	CcSEcCtD
Cefepime—Dyspnoea—Captopril—systemic scleroderma	0.000501	0.00185	CcSEcCtD
Cefepime—Anaemia—Mycophenolic acid—systemic scleroderma	0.0005	0.00185	CcSEcCtD
Cefepime—Agitation—Mycophenolic acid—systemic scleroderma	0.000497	0.00184	CcSEcCtD
Cefepime—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00182	CcSEcCtD
Cefepime—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00181	CcSEcCtD
Cefepime—Dizziness—Pentoxifylline—systemic scleroderma	0.00049	0.00181	CcSEcCtD
Cefepime—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000488	0.0018	CcSEcCtD
Cefepime—Erythema—Lisinopril—systemic scleroderma	0.000488	0.0018	CcSEcCtD
Cefepime—Infection—Azathioprine—systemic scleroderma	0.000487	0.0018	CcSEcCtD
Cefepime—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000485	0.00179	CcSEcCtD
Cefepime—Constipation—Captopril—systemic scleroderma	0.00048	0.00178	CcSEcCtD
Cefepime—Sepsis—Methotrexate—systemic scleroderma	0.00048	0.00178	CcSEcCtD
Cefepime—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00048	0.00177	CcSEcCtD
Cefepime—Dysgeusia—Lisinopril—systemic scleroderma	0.000477	0.00176	CcSEcCtD
Cefepime—Vomiting—Pentoxifylline—systemic scleroderma	0.000471	0.00174	CcSEcCtD
Cefepime—Convulsion—Mycophenolic acid—systemic scleroderma	0.000469	0.00173	CcSEcCtD
Cefepime—Rash—Pentoxifylline—systemic scleroderma	0.000467	0.00173	CcSEcCtD
Cefepime—Dermatitis—Pentoxifylline—systemic scleroderma	0.000467	0.00173	CcSEcCtD
Cefepime—Headache—Pentoxifylline—systemic scleroderma	0.000464	0.00172	CcSEcCtD
Cefepime—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000463	0.00171	CcSEcCtD
Cefepime—Feeling abnormal—Captopril—systemic scleroderma	0.000463	0.00171	CcSEcCtD
Cefepime—Infection—Leflunomide—systemic scleroderma	0.00046	0.0017	CcSEcCtD
Cefepime—Gastrointestinal pain—Captopril—systemic scleroderma	0.000459	0.0017	CcSEcCtD
Cefepime—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000453	0.00168	CcSEcCtD
Cefepime—Pruritus—Mometasone—systemic scleroderma	0.000453	0.00167	CcSEcCtD
Cefepime—Anaemia—Lisinopril—systemic scleroderma	0.000451	0.00167	CcSEcCtD
Cefepime—Hepatic failure—Methotrexate—systemic scleroderma	0.000447	0.00165	CcSEcCtD
Cefepime—Confusional state—Mycophenolic acid—systemic scleroderma	0.000445	0.00165	CcSEcCtD
Cefepime—Body temperature increased—Captopril—systemic scleroderma	0.000444	0.00164	CcSEcCtD
Cefepime—Abdominal pain—Captopril—systemic scleroderma	0.000444	0.00164	CcSEcCtD
Cefepime—Nausea—Pentoxifylline—systemic scleroderma	0.00044	0.00163	CcSEcCtD
Cefepime—Chills—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00163	CcSEcCtD
Cefepime—Infection—Mycophenolic acid—systemic scleroderma	0.000439	0.00162	CcSEcCtD
Cefepime—Diarrhoea—Mometasone—systemic scleroderma	0.000438	0.00162	CcSEcCtD
Cefepime—Leukopenia—Lisinopril—systemic scleroderma	0.000436	0.00161	CcSEcCtD
Cefepime—Shock—Mycophenolic acid—systemic scleroderma	0.000435	0.00161	CcSEcCtD
Cefepime—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000433	0.0016	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000424	0.00157	CcSEcCtD
Cefepime—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000423	0.00156	CcSEcCtD
Cefepime—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000418	0.00155	CcSEcCtD
Cefepime—Paraesthesia—Leflunomide—systemic scleroderma	0.000416	0.00154	CcSEcCtD
Cefepime—Dyspnoea—Leflunomide—systemic scleroderma	0.000413	0.00153	CcSEcCtD
Cefepime—Vomiting—Mometasone—systemic scleroderma	0.000407	0.0015	CcSEcCtD
Cefepime—Feeling abnormal—Azathioprine—systemic scleroderma	0.000404	0.00149	CcSEcCtD
Cefepime—Rash—Mometasone—systemic scleroderma	0.000403	0.00149	CcSEcCtD
Cefepime—Dermatitis—Mometasone—systemic scleroderma	0.000403	0.00149	CcSEcCtD
Cefepime—Confusional state—Lisinopril—systemic scleroderma	0.000401	0.00148	CcSEcCtD
Cefepime—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000401	0.00148	CcSEcCtD
Cefepime—Headache—Mometasone—systemic scleroderma	0.000401	0.00148	CcSEcCtD
Cefepime—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.0004	0.00148	CcSEcCtD
Cefepime—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000398	0.00147	CcSEcCtD
Cefepime—Pruritus—Captopril—systemic scleroderma	0.000398	0.00147	CcSEcCtD
Cefepime—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000397	0.00147	CcSEcCtD
Cefepime—Pain—Leflunomide—systemic scleroderma	0.000396	0.00146	CcSEcCtD
Cefepime—Constipation—Leflunomide—systemic scleroderma	0.000396	0.00146	CcSEcCtD
Cefepime—Infection—Lisinopril—systemic scleroderma	0.000395	0.00146	CcSEcCtD
Cefepime—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000395	0.00146	CcSEcCtD
Cefepime—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000394	0.00146	CcSEcCtD
Cefepime—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000393	0.00145	CcSEcCtD
Cefepime—Shock—Lisinopril—systemic scleroderma	0.000391	0.00145	CcSEcCtD
Cefepime—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00039	0.00144	CcSEcCtD
Cefepime—Neutropenia—Prednisone—systemic scleroderma	0.000389	0.00144	CcSEcCtD
Cefepime—Body temperature increased—Azathioprine—systemic scleroderma	0.000388	0.00143	CcSEcCtD
Cefepime—Abdominal pain—Azathioprine—systemic scleroderma	0.000388	0.00143	CcSEcCtD
Cefepime—Diarrhoea—Captopril—systemic scleroderma	0.000384	0.00142	CcSEcCtD
Cefepime—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00141	CcSEcCtD
Cefepime—Feeling abnormal—Leflunomide—systemic scleroderma	0.000382	0.00141	CcSEcCtD
Cefepime—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000381	0.00141	CcSEcCtD
Cefepime—Nausea—Mometasone—systemic scleroderma	0.00038	0.0014	CcSEcCtD
Cefepime—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000379	0.0014	CcSEcCtD
Cefepime—Pain—Mycophenolic acid—systemic scleroderma	0.000378	0.0014	CcSEcCtD
Cefepime—Constipation—Mycophenolic acid—systemic scleroderma	0.000378	0.0014	CcSEcCtD
Cefepime—Dizziness—Captopril—systemic scleroderma	0.000372	0.00137	CcSEcCtD
Cefepime—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00137	CcSEcCtD
Cefepime—Urticaria—Leflunomide—systemic scleroderma	0.000368	0.00136	CcSEcCtD
Cefepime—Abdominal pain—Leflunomide—systemic scleroderma	0.000366	0.00135	CcSEcCtD
Cefepime—Body temperature increased—Leflunomide—systemic scleroderma	0.000366	0.00135	CcSEcCtD
Cefepime—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000364	0.00135	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000362	0.00134	CcSEcCtD
Cefepime—Hypersensitivity—Azathioprine—systemic scleroderma	0.000361	0.00133	CcSEcCtD
Cefepime—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000361	0.00133	CcSEcCtD
Cefepime—Paraesthesia—Lisinopril—systemic scleroderma	0.000357	0.00132	CcSEcCtD
Cefepime—Vomiting—Captopril—systemic scleroderma	0.000357	0.00132	CcSEcCtD
Cefepime—Dyspnoea—Lisinopril—systemic scleroderma	0.000355	0.00131	CcSEcCtD
Cefepime—Rash—Captopril—systemic scleroderma	0.000354	0.00131	CcSEcCtD
Cefepime—Dermatitis—Captopril—systemic scleroderma	0.000354	0.00131	CcSEcCtD
Cefepime—Headache—Captopril—systemic scleroderma	0.000352	0.0013	CcSEcCtD
Cefepime—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000352	0.0013	CcSEcCtD
Cefepime—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000349	0.00129	CcSEcCtD
Cefepime—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000349	0.00129	CcSEcCtD
Cefepime—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00129	CcSEcCtD
Cefepime—Infection—Mycophenolate mofetil—systemic scleroderma	0.000346	0.00128	CcSEcCtD
Cefepime—Eosinophilia—Methotrexate—systemic scleroderma	0.000344	0.00127	CcSEcCtD
Cefepime—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000344	0.00127	CcSEcCtD
Cefepime—Shock—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00127	CcSEcCtD
Cefepime—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00126	CcSEcCtD
Cefepime—Hypersensitivity—Leflunomide—systemic scleroderma	0.000341	0.00126	CcSEcCtD
Cefepime—Pain—Lisinopril—systemic scleroderma	0.00034	0.00126	CcSEcCtD
Cefepime—Constipation—Lisinopril—systemic scleroderma	0.00034	0.00126	CcSEcCtD
Cefepime—Diarrhoea—Azathioprine—systemic scleroderma	0.000336	0.00124	CcSEcCtD
Cefepime—Haemoglobin—Prednisone—systemic scleroderma	0.000334	0.00124	CcSEcCtD
Cefepime—Nausea—Captopril—systemic scleroderma	0.000334	0.00123	CcSEcCtD
Cefepime—Haemorrhage—Prednisone—systemic scleroderma	0.000333	0.00123	CcSEcCtD
Cefepime—Hallucination—Prednisone—systemic scleroderma	0.000331	0.00122	CcSEcCtD
Cefepime—Pancytopenia—Methotrexate—systemic scleroderma	0.00033	0.00122	CcSEcCtD
Cefepime—Feeling abnormal—Lisinopril—systemic scleroderma	0.000328	0.00121	CcSEcCtD
Cefepime—Pruritus—Leflunomide—systemic scleroderma	0.000328	0.00121	CcSEcCtD
Cefepime—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000325	0.0012	CcSEcCtD
Cefepime—Neutropenia—Methotrexate—systemic scleroderma	0.000325	0.0012	CcSEcCtD
Cefepime—Dizziness—Azathioprine—systemic scleroderma	0.000324	0.0012	CcSEcCtD
Cefepime—Diarrhoea—Leflunomide—systemic scleroderma	0.000317	0.00117	CcSEcCtD
Cefepime—Urticaria—Lisinopril—systemic scleroderma	0.000316	0.00117	CcSEcCtD
Cefepime—Abdominal pain—Lisinopril—systemic scleroderma	0.000315	0.00116	CcSEcCtD
Cefepime—Body temperature increased—Lisinopril—systemic scleroderma	0.000315	0.00116	CcSEcCtD
Cefepime—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00116	CcSEcCtD
Cefepime—Pruritus—Mycophenolic acid—systemic scleroderma	0.000313	0.00115	CcSEcCtD
Cefepime—Vomiting—Azathioprine—systemic scleroderma	0.000312	0.00115	CcSEcCtD
Cefepime—Pneumonia—Methotrexate—systemic scleroderma	0.000311	0.00115	CcSEcCtD
Cefepime—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000311	0.00115	CcSEcCtD
Cefepime—Rash—Azathioprine—systemic scleroderma	0.000309	0.00114	CcSEcCtD
Cefepime—Dermatitis—Azathioprine—systemic scleroderma	0.000309	0.00114	CcSEcCtD
Cefepime—Headache—Azathioprine—systemic scleroderma	0.000307	0.00114	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000307	0.00113	CcSEcCtD
Cefepime—Dizziness—Leflunomide—systemic scleroderma	0.000306	0.00113	CcSEcCtD
Cefepime—Renal failure—Methotrexate—systemic scleroderma	0.000304	0.00112	CcSEcCtD
Cefepime—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000302	0.00112	CcSEcCtD
Cefepime—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00111	CcSEcCtD
Cefepime—Pain—Mycophenolate mofetil—systemic scleroderma	0.000298	0.0011	CcSEcCtD
Cefepime—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000298	0.0011	CcSEcCtD
Cefepime—Vomiting—Leflunomide—systemic scleroderma	0.000294	0.00109	CcSEcCtD
Cefepime—Hypersensitivity—Lisinopril—systemic scleroderma	0.000293	0.00108	CcSEcCtD
Cefepime—Dizziness—Mycophenolic acid—systemic scleroderma	0.000292	0.00108	CcSEcCtD
Cefepime—Rash—Leflunomide—systemic scleroderma	0.000292	0.00108	CcSEcCtD
Cefepime—Dermatitis—Leflunomide—systemic scleroderma	0.000292	0.00108	CcSEcCtD
Cefepime—Nausea—Azathioprine—systemic scleroderma	0.000291	0.00108	CcSEcCtD
Cefepime—Headache—Leflunomide—systemic scleroderma	0.00029	0.00107	CcSEcCtD
Cefepime—Erythema—Prednisone—systemic scleroderma	0.00029	0.00107	CcSEcCtD
Cefepime—Agranulocytosis—Methotrexate—systemic scleroderma	0.000289	0.00107	CcSEcCtD
Cefepime—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00106	CcSEcCtD
Cefepime—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00105	CcSEcCtD
Cefepime—Pruritus—Lisinopril—systemic scleroderma	0.000282	0.00104	CcSEcCtD
Cefepime—Vomiting—Mycophenolic acid—systemic scleroderma	0.000281	0.00104	CcSEcCtD
Cefepime—Haemoglobin—Methotrexate—systemic scleroderma	0.000279	0.00103	CcSEcCtD
Cefepime—Rash—Mycophenolic acid—systemic scleroderma	0.000279	0.00103	CcSEcCtD
Cefepime—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000278	0.00103	CcSEcCtD
Cefepime—Haemorrhage—Methotrexate—systemic scleroderma	0.000278	0.00103	CcSEcCtD
Cefepime—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00102	CcSEcCtD
Cefepime—Headache—Mycophenolic acid—systemic scleroderma	0.000277	0.00102	CcSEcCtD
Cefepime—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000276	0.00102	CcSEcCtD
Cefepime—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000276	0.00102	CcSEcCtD
Cefepime—Nausea—Leflunomide—systemic scleroderma	0.000275	0.00102	CcSEcCtD
Cefepime—Diarrhoea—Lisinopril—systemic scleroderma	0.000272	0.00101	CcSEcCtD
Cefepime—Anaemia—Prednisone—systemic scleroderma	0.000268	0.000989	CcSEcCtD
Cefepime—Agitation—Prednisone—systemic scleroderma	0.000266	0.000983	CcSEcCtD
Cefepime—Dizziness—Lisinopril—systemic scleroderma	0.000263	0.000972	CcSEcCtD
Cefepime—Erythema multiforme—Methotrexate—systemic scleroderma	0.000263	0.000971	CcSEcCtD
Cefepime—Nausea—Mycophenolic acid—systemic scleroderma	0.000262	0.00097	CcSEcCtD
Cefepime—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000949	CcSEcCtD
Cefepime—Vomiting—Lisinopril—systemic scleroderma	0.000253	0.000935	CcSEcCtD
Cefepime—Rash—Lisinopril—systemic scleroderma	0.000251	0.000927	CcSEcCtD
Cefepime—Convulsion—Prednisone—systemic scleroderma	0.000251	0.000927	CcSEcCtD
Cefepime—Dermatitis—Lisinopril—systemic scleroderma	0.000251	0.000926	CcSEcCtD
Cefepime—Chills—Methotrexate—systemic scleroderma	0.000249	0.000922	CcSEcCtD
Cefepime—Headache—Lisinopril—systemic scleroderma	0.000249	0.000921	CcSEcCtD
Cefepime—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000911	CcSEcCtD
Cefepime—Erythema—Methotrexate—systemic scleroderma	0.000242	0.000894	CcSEcCtD
Cefepime—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000881	CcSEcCtD
Cefepime—Dysgeusia—Methotrexate—systemic scleroderma	0.000237	0.000876	CcSEcCtD
Cefepime—Nausea—Lisinopril—systemic scleroderma	0.000236	0.000873	CcSEcCtD
Cefepime—Anaphylactic shock—Prednisone—systemic scleroderma	0.000236	0.000873	CcSEcCtD
Cefepime—Infection—Prednisone—systemic scleroderma	0.000235	0.000868	CcSEcCtD
Cefepime—Shock—Prednisone—systemic scleroderma	0.000232	0.000859	CcSEcCtD
Cefepime—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000852	CcSEcCtD
Cefepime—Anaemia—Methotrexate—systemic scleroderma	0.000224	0.000826	CcSEcCtD
Cefepime—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000819	CcSEcCtD
Cefepime—Rash—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000812	CcSEcCtD
Cefepime—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000812	CcSEcCtD
Cefepime—Headache—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000807	CcSEcCtD
Cefepime—Leukopenia—Methotrexate—systemic scleroderma	0.000217	0.0008	CcSEcCtD
Cefepime—Paraesthesia—Prednisone—systemic scleroderma	0.000212	0.000784	CcSEcCtD
Cefepime—Convulsion—Methotrexate—systemic scleroderma	0.00021	0.000775	CcSEcCtD
Cefepime—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000765	CcSEcCtD
Cefepime—Constipation—Prednisone—systemic scleroderma	0.000202	0.000747	CcSEcCtD
Cefepime—Confusional state—Methotrexate—systemic scleroderma	0.000199	0.000736	CcSEcCtD
Cefepime—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000197	0.00073	CcSEcCtD
Cefepime—Infection—Methotrexate—systemic scleroderma	0.000196	0.000725	CcSEcCtD
Cefepime—Feeling abnormal—Prednisone—systemic scleroderma	0.000195	0.00072	CcSEcCtD
Cefepime—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000193	0.000715	CcSEcCtD
Cefepime—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000193	0.000714	CcSEcCtD
Cefepime—Urticaria—Prednisone—systemic scleroderma	0.000188	0.000694	CcSEcCtD
Cefepime—Abdominal pain—Prednisone—systemic scleroderma	0.000187	0.00069	CcSEcCtD
Cefepime—Body temperature increased—Prednisone—systemic scleroderma	0.000187	0.00069	CcSEcCtD
Cefepime—Paraesthesia—Methotrexate—systemic scleroderma	0.000177	0.000655	CcSEcCtD
Cefepime—Dyspnoea—Methotrexate—systemic scleroderma	0.000176	0.000651	CcSEcCtD
Cefepime—Hypersensitivity—Prednisone—systemic scleroderma	0.000174	0.000643	CcSEcCtD
Cefepime—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000171	0.00063	CcSEcCtD
Cefepime—Pain—Methotrexate—systemic scleroderma	0.000169	0.000624	CcSEcCtD
Cefepime—Pruritus—Prednisone—systemic scleroderma	0.000167	0.000618	CcSEcCtD
Cefepime—Feeling abnormal—Methotrexate—systemic scleroderma	0.000163	0.000601	CcSEcCtD
Cefepime—Diarrhoea—Prednisone—systemic scleroderma	0.000162	0.000597	CcSEcCtD
Cefepime—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000161	0.000597	CcSEcCtD
Cefepime—Urticaria—Methotrexate—systemic scleroderma	0.000157	0.00058	CcSEcCtD
Cefepime—Dizziness—Prednisone—systemic scleroderma	0.000156	0.000577	CcSEcCtD
Cefepime—Abdominal pain—Methotrexate—systemic scleroderma	0.000156	0.000577	CcSEcCtD
Cefepime—Body temperature increased—Methotrexate—systemic scleroderma	0.000156	0.000577	CcSEcCtD
Cefepime—Vomiting—Prednisone—systemic scleroderma	0.00015	0.000555	CcSEcCtD
Cefepime—Rash—Prednisone—systemic scleroderma	0.000149	0.000551	CcSEcCtD
Cefepime—Dermatitis—Prednisone—systemic scleroderma	0.000149	0.00055	CcSEcCtD
Cefepime—Headache—Prednisone—systemic scleroderma	0.000148	0.000547	CcSEcCtD
Cefepime—Hypersensitivity—Methotrexate—systemic scleroderma	0.000146	0.000538	CcSEcCtD
Cefepime—Nausea—Prednisone—systemic scleroderma	0.00014	0.000519	CcSEcCtD
Cefepime—Pruritus—Methotrexate—systemic scleroderma	0.00014	0.000516	CcSEcCtD
Cefepime—Diarrhoea—Methotrexate—systemic scleroderma	0.000135	0.000499	CcSEcCtD
Cefepime—Dizziness—Methotrexate—systemic scleroderma	0.000131	0.000483	CcSEcCtD
Cefepime—Vomiting—Methotrexate—systemic scleroderma	0.000126	0.000464	CcSEcCtD
Cefepime—Rash—Methotrexate—systemic scleroderma	0.000125	0.00046	CcSEcCtD
Cefepime—Dermatitis—Methotrexate—systemic scleroderma	0.000124	0.00046	CcSEcCtD
Cefepime—Headache—Methotrexate—systemic scleroderma	0.000124	0.000457	CcSEcCtD
Cefepime—Nausea—Methotrexate—systemic scleroderma	0.000117	0.000433	CcSEcCtD
